Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Capitol Hill Lawmakers Could Revisit Pearson, DSHEA In 2001

This article was originally published in The Tan Sheet

Executive Summary

Congressional leaders may be looking to the 107th Congress to initiate hearings on FDA's actions in implementing the Pearson v. Shalala decision.

You may also be interested in...



CFSAN Congressional Reports On DSHEA, Pearson, Strategic Plan Slated

The Center for Food Safety & Applied Nutrition will submit reports to Congress this fiscal year on the cost of addressing various dietary supplement issues.

CFSAN Congressional Reports On DSHEA, Pearson, Strategic Plan Slated

The Center for Food Safety & Applied Nutrition will submit reports to Congress this fiscal year on the cost of addressing various dietary supplement issues.

FDA budget

Senate vote on agriculture approps bill expected Oct. 18. Conference report on HR 4461 passed House by a 340-75 vote Oct. 11. Bill provides FDA with $1.22 bil. for fiscal 2001, including salaries, expenses and majority of user fees. CDER receives $317.5 mil., with $6.8 mil. earmarked for adverse event monitoring of drugs. AER funding for dietary supplements/foods is removed in conference report, committee says. CFSAN and its field offices are allocated $285.3 mil., a $30 mil. increase over FY 2000 budget. Food center also is granted $1 mil. to fund a joint University of Mississippi dietary supplement research center

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091786

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel